Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Eli Lilly building

Lilly’s ulcerative colitis treatment meets all key endpoints in Phase III trial

March 17, 2021 Research and Development Eli Lilly, Phase III trial, lilly, mirikizumab, ulcerative colitis

Eli Lilly’s mirikizumab treatment for ulcerative colitis (UC) patients has met the primary endpoints and all key secondary endpoints in …
News

Axol Bioscience and CENSO Biotechnologies enter merger agreement

March 17, 2021 Research and Development Axol Bioscience, Censo Biotechnologies, immune cell, merger, neuroscience

Axol Bioscience, an established provider of iPSC-derived cells, media, and characterisation services, and CENSO Biotechnologies, a cell biology CRO focused …
News

PEP-Therapy and Institut Curie’s cancer drug trial approved in France

March 17, 2021 Research and Development Cancer, France, Pep-therapy

PEP-Therapy and Institut Curie have been granted approval from the French National Agency for Medicines and Health Products (ANSM) to …
News

Medicago & GSK start plant-derived COVID-19 vaccine trial

March 17, 2021 Research and Development COVID-19, GSK

Medicago and GSK have announced the start of Phase III clinical testing of Medicago’s plant-derived COVID-19 vaccine. The vaccine candidate …
News
coronavirus

Pharmafile.com’s weekly COVID-19 news round-up

March 10, 2021 Research and Development COVID, COVID Vaccine, COVID-19, coronavirus, covid round-up

The past week has continued to see positive COVID-19 news; CytoDyn’s treatment for patients with severe symptoms of the virus …
News
lilly_entrance_web

Lilly’s cancer drug Retsevmo gets UK approval for multiple indications

March 10, 2021 Research and Development Cancer, Eli Lilly, MHRA

The MHRA has granted conditional marketing authorisation for Eli Lilly’s Retsevmo (selpercatinib) as monotherapy for a number of cancer indications.
News
Takeda building

Takeda acquire Maverick in $525m deal to expand cancer therapy portfolio

March 10, 2021 Research and Development Maverick, Takeda, cancer treatment

Takeda has acquired Maverick Therapeutics in a deal worth up to $525 million, in order to expand its portfolio of …
News
evonik__chemie_foto_001

Evonik and Cassava Sciences enter supply agreement for Alzheimer’s drug candidate

March 10, 2021 Research and Development Alzheimer's, Cassava Sciences, Evonik

Evonik has entered into an agreement to supply Cassava Sciences with large-scale, clinical-grade quantities of simufilam, a drug candidate for …
News

Affinivax receives $22m funding for development of Staphylococcus aureus vaccine

March 10, 2021 Research and Development Affinivax, bacteria, vaccines

Affinivax has received an award of $22 million funding from CARB-X, a global non-profit organisation, to develop a vaccine targeting Staphylococcus …
News
COVID-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

March 3, 2021 Research and Development

The past week has continued to see positive COVID-19 news; COVAX has delivered their first batch of vaccines to Africa, …
News

ViaCyte and Gore collaborate on new diabetes treatments

March 3, 2021 Research and Development Type 1 diabetes, diabetes, diabetes treatment, gore, viacyte

Clinical stage medicine company ViaCyte have extended their collaboration with materials science organisation Gore to develop new candidates for the …
News
abbvie

AbbVie funds Mitokinin’s Parkinson’s research with option to buy

March 3, 2021 Research and Development AbbVie, Mitokinin, Parkinson's

AbbVie has landed an option to buy neurodegenerative disease-focused biotech Mitokinin following completion of investigational new drug (IND)-enabling studies on …
News
mavenclad

NHS England increases access to cladribine tablets for multiple sclerosis patients during pandemic

March 3, 2021 Research and Development Cladribine, Mavenclad, Merck, multiple sclerosis

NHS England has updated the Blueteq requirements for patients with highly active relapsing MS starting Merck’s cladribine (Mavenclad) tablets during …
News
astrazeneca_plaque

AstraZeneca wins US court ruling on Symbicort patent claims

March 3, 2021 Research and Development AstraZeneca, Symbicort, law

A US district court has ruled in favour of AstraZeneca in litigation against Mylan Pharmaceuticals and Kindeva Drug Delivery, AstraZeneca …
News

Verona Pharma appoints Novartis Gene Therapies VP Lisa Deschamps to its board

March 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, verona, verona pharma

Verona Pharma has appointed Lisa Deschamps, Senior Vice President and Chief Business Officer of Novartis Gene Therapies, as Non-Executive Director …
Appointment
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026